Aquilo Capital Management, LLC's most recent trades

10% Owner

COMPANY

NET TOTAL

19.47%

SPDR S&P BIOTECH ETF TR

750,000

$55,703,000.00

14.75%

ARROWHEAD PHARMACEUTICALS IN

1,198,515

$42,200,000.00

12.65%

BLUEPRINT MEDICINES CORP

716,539

$36,192,000.00

11.69%

MERUS N V

1,477,109

$33,442,000.00

11.36%

ARVINAS INC

771,745

$32,483,000.00

10.08%

REGENXBIO INC

1,167,684

$28,842,000.00

6.33%

UNIQURE NV

971,490

$18,109,000.00

4.56%

AMRYT PHARMA PLC

1,866,652

$13,048,000.00

3.18%

ARGENX SE

24,000

$9,093,000.00

2.44%

PIERIS PHARMACEUTICALS INC

3,736,280

$6,987,000.00

2.10%

4D MOLECULAR THERAPEUTICS IN

861,607

$6,014,000.00

1.38%

SPERO THERAPEUTICS INC

5,321,231

$3,943,000.00